共 39 条
- [31] Galenus von Pergamon Prize 2023-the candidates. Gastrointestinal stromal tumors: Qinlock® - opportunity in the fourth line of therapy INNERE MEDIZIN, 2023, 64 (09): : 910 - 910
- [32] Galenus von Pergamon Prize 2013 Outstanding Drug Innovations in the Competition for the coveted Award GASTROENTEROLOGE, 2013, 8 (05): : 434 - 434
- [33] Galenus von Pergamon Prize 2023-the candidates. Brukinsa® for chronic lymphocytic leukemia - highly effective and good cardiac tolerance INNERE MEDIZIN, 2023, 64 (09): : 906 - 906
- [34] Galenus von Pergamon Prize 2023-the candidates. Control severe bronchial asthma: New biologic works regardless of phenotype INNERE MEDIZIN, 2023, 64 (10): : 944 - 944
- [35] Galenus-von-Pergamon-Prize 2014 Desired Award for Outstanding Pharmaceutical-Innovations PNEUMOLOGE, 2014, 11 (05): : 401 - 401
- [36] Galenus von Pergamon Award 2023-The Candidates Hamolysis in Patients with paroxysmal nocturnal Hemoglobinuria INNERE MEDIZIN, 2023, 64 (08): : 757 - 757
- [37] New action principle recognized - Losartan as innovation in angiotensin-II-antagonists receives the Galenus-von-Pergamon Prize INTERNIST, 1998, 39 (02): : A41 - A42
- [38] Galenus von Pergamon Award 2023-The Candidates. Quviviq™ - new Active Principle against overactive Waking System in Insomnia INNERE MEDIZIN, 2023, 64 (08): : 817 - 817
- [39] Galenus von Pergamon Award 2023-The Candidates Quviviq™ - new Active Principle against overactive Waking System in Patients with Insomnia SOMNOLOGIE, 2023, 27 (03): : 157 - 157